Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environmental Exposure | 7 | 2016 | 372 | 1.840 |
Why?
|
| Occupational Exposure | 5 | 2021 | 255 | 1.660 |
Why?
|
| Particulate Matter | 3 | 2016 | 185 | 1.390 |
Why?
|
| Benzhydryl Compounds | 2 | 2023 | 59 | 1.370 |
Why?
|
| Phenols | 2 | 2023 | 82 | 1.350 |
Why?
|
| Environmental Pollutants | 4 | 2016 | 110 | 1.250 |
Why?
|
| Asbestos, Amphibole | 2 | 2016 | 2 | 0.980 |
Why?
|
| Air Pollutants | 4 | 2015 | 244 | 0.940 |
Why?
|
| Ozone | 4 | 2015 | 99 | 0.780 |
Why?
|
| Asbestos | 1 | 2021 | 19 | 0.770 |
Why?
|
| Inhalation Exposure | 2 | 2013 | 96 | 0.750 |
Why?
|
| Risk Assessment | 12 | 2021 | 2958 | 0.740 |
Why?
|
| Air Pollutants, Occupational | 2 | 2018 | 27 | 0.680 |
Why?
|
| Asbestos, Serpentine | 2 | 2021 | 4 | 0.640 |
Why?
|
| Endocrine Disruptors | 3 | 2015 | 34 | 0.630 |
Why?
|
| United States Environmental Protection Agency | 3 | 2015 | 23 | 0.620 |
Why?
|
| Toluene 2,4-Diisocyanate | 1 | 2018 | 2 | 0.620 |
Why?
|
| Asthma, Occupational | 1 | 2018 | 4 | 0.610 |
Why?
|
| Benzoic Acid | 1 | 2017 | 4 | 0.580 |
Why?
|
| Food Additives | 1 | 2017 | 7 | 0.580 |
Why?
|
| Nitrogen Dioxide | 1 | 2017 | 20 | 0.570 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 60 | 0.560 |
Why?
|
| Research | 1 | 2020 | 389 | 0.540 |
Why?
|
| Reproduction | 1 | 2017 | 176 | 0.500 |
Why?
|
| Sulfur Dioxide | 2 | 2015 | 7 | 0.480 |
Why?
|
| Neoplasms | 2 | 2020 | 2086 | 0.470 |
Why?
|
| Science | 1 | 2015 | 48 | 0.460 |
Why?
|
| Mortality | 1 | 2016 | 283 | 0.450 |
Why?
|
| Allergens | 1 | 2017 | 410 | 0.440 |
Why?
|
| Environmental Monitoring | 2 | 2015 | 255 | 0.440 |
Why?
|
| Air Pollution | 2 | 2015 | 169 | 0.440 |
Why?
|
| Mesothelioma | 1 | 2013 | 31 | 0.430 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 2159 | 0.410 |
Why?
|
| Models, Theoretical | 1 | 2016 | 513 | 0.400 |
Why?
|
| Atherosclerosis | 1 | 2015 | 342 | 0.390 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1032 | 0.350 |
Why?
|
| Dioxins | 1 | 2010 | 4 | 0.350 |
Why?
|
| Toxicity Tests | 3 | 2016 | 28 | 0.340 |
Why?
|
| Thyroid Hormones | 1 | 2010 | 53 | 0.340 |
Why?
|
| Thyroid Gland | 1 | 2010 | 85 | 0.330 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2009 | 3 | 0.320 |
Why?
|
| Flame Retardants | 1 | 2009 | 8 | 0.320 |
Why?
|
| Methyl Ethers | 1 | 2007 | 7 | 0.300 |
Why?
|
| Leydig Cell Tumor | 1 | 2007 | 8 | 0.300 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 1726 | 0.290 |
Why?
|
| Asthma | 2 | 2017 | 2021 | 0.280 |
Why?
|
| Animals | 13 | 2023 | 31565 | 0.280 |
Why?
|
| Humans | 23 | 2023 | 114045 | 0.270 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 96 | 0.270 |
Why?
|
| Lung | 2 | 2016 | 3521 | 0.260 |
Why?
|
| Behavior, Animal | 1 | 2009 | 459 | 0.250 |
Why?
|
| Rats | 4 | 2017 | 4913 | 0.240 |
Why?
|
| Survival Analysis | 1 | 2007 | 1206 | 0.230 |
Why?
|
| Models, Statistical | 1 | 2007 | 595 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 1836 | 0.220 |
Why?
|
| Public Health | 2 | 2020 | 433 | 0.210 |
Why?
|
| Respiratory Function Tests | 2 | 2015 | 522 | 0.180 |
Why?
|
| United States | 5 | 2021 | 12137 | 0.180 |
Why?
|
| International Agencies | 1 | 2020 | 29 | 0.170 |
Why?
|
| No-Observed-Adverse-Effect Level | 2 | 2017 | 5 | 0.170 |
Why?
|
| Carcinogens | 1 | 2020 | 102 | 0.160 |
Why?
|
| Threshold Limit Values | 1 | 2018 | 1 | 0.150 |
Why?
|
| Risk Factors | 3 | 2023 | 8614 | 0.150 |
Why?
|
| Species Specificity | 2 | 2017 | 541 | 0.150 |
Why?
|
| Brain | 1 | 2009 | 2355 | 0.140 |
Why?
|
| Salts | 1 | 2017 | 36 | 0.140 |
Why?
|
| Recommended Dietary Allowances | 1 | 2017 | 18 | 0.140 |
Why?
|
| Maximum Allowable Concentration | 1 | 2017 | 14 | 0.140 |
Why?
|
| Uncertainty | 1 | 2017 | 91 | 0.140 |
Why?
|
| Montana | 1 | 2016 | 16 | 0.130 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 72 | 0.130 |
Why?
|
| Legislation, Drug | 1 | 2017 | 78 | 0.130 |
Why?
|
| Occupational Health | 1 | 2018 | 165 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2016 | 168 | 0.130 |
Why?
|
| California | 1 | 2017 | 351 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2015 | 48 | 0.130 |
Why?
|
| Review Literature as Topic | 1 | 2015 | 61 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2537 | 0.120 |
Why?
|
| Sulfuric Acids | 1 | 2015 | 10 | 0.120 |
Why?
|
| DNA Repair | 1 | 2016 | 184 | 0.120 |
Why?
|
| Models, Animal | 1 | 2016 | 340 | 0.120 |
Why?
|
| DNA Damage | 1 | 2016 | 351 | 0.110 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2013 | 8 | 0.110 |
Why?
|
| Decision Making | 1 | 2020 | 760 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2015 | 126 | 0.110 |
Why?
|
| Europe | 1 | 2013 | 332 | 0.100 |
Why?
|
| Time Factors | 2 | 2015 | 6077 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2016 | 493 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 318 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1145 | 0.090 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2010 | 7 | 0.090 |
Why?
|
| Benzofurans | 1 | 2010 | 18 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 919 | 0.090 |
Why?
|
| Thyrotropin | 1 | 2010 | 100 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2015 | 817 | 0.080 |
Why?
|
| Inflammation | 1 | 2020 | 2464 | 0.080 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2009 | 14 | 0.080 |
Why?
|
| Manganese | 1 | 2009 | 55 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 1 | 2010 | 139 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 159 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 777 | 0.070 |
Why?
|
| Mice | 2 | 2015 | 14843 | 0.070 |
Why?
|
| Nicotine | 1 | 2009 | 265 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2012 | 3861 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 635 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 2182 | 0.050 |
Why?
|
| Biomarkers | 1 | 2010 | 3397 | 0.040 |
Why?
|
| Female | 2 | 2017 | 59324 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 10444 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2010 | 5038 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2020 | 144 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2020 | 115 | 0.040 |
Why?
|
| Adolescent | 1 | 2015 | 17800 | 0.030 |
Why?
|
| Male | 2 | 2015 | 55396 | 0.030 |
Why?
|
| Middle Aged | 1 | 2015 | 26605 | 0.030 |
Why?
|
| Bias | 1 | 2015 | 178 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1577 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 241 | 0.030 |
Why?
|
| Adult | 1 | 2015 | 30375 | 0.030 |
Why?
|
| World Health Organization | 1 | 2014 | 101 | 0.030 |
Why?
|
| Benchmarking | 1 | 2009 | 161 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 739 | 0.020 |
Why?
|